Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Colorcon
Moodys
Deloitte
McKesson
Mallinckrodt
Cipla
Federal Trade Commission
Fuji

Generated: February 21, 2018

DrugPatentWatch Database Preview

NEVIRAPINE Drug Profile

« Back to Dashboard

Which patents cover Nevirapine, and what generic alternatives are available?

Nevirapine is a drug marketed by Aurobindo, Cipla Ltd, Alvogen Malta, Apotex Inc, Aurobindo Pharma Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Sandoz Inc, Tech Organized, Cipla, Hetero Labs Ltd Iii, Micro Labs Ltd, Mylan Labs, Prinston Inc, and Strides Pharma. and is included in twenty-two NDAs.

The generic ingredient in NEVIRAPINE is nevirapine. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. There are seven tentative approvals for this compound. Additional details are available on the nevirapine profile page.

US Patents and Regulatory Information for NEVIRAPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo NEVIRAPINE nevirapine SUSPENSION;ORAL 077702-001 May 22, 2012 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hetero Labs Ltd Iii NEVIRAPINE nevirapine TABLET;ORAL 078584-001 May 22, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Tech Organized NEVIRAPINE nevirapine TABLET;ORAL 203176-001 May 22, 2012 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 207698-001 Feb 28, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alvogen Malta NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 204621-001 Jul 10, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 203411-001 Apr 3, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs NEVIRAPINE nevirapine TABLET;ORAL 078864-001 May 22, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cipla Ltd NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 206448-001 Oct 15, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Micro Labs Ltd NEVIRAPINE nevirapine TABLET;ORAL 203080-001 May 22, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo NEVIRAPINE nevirapine TABLET;ORAL 077521-001 May 22, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
UBS
Cerilliant
Cipla
Fuji
Queensland Health
Chinese Patent Office
Federal Trade Commission
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot